Organigram Holdings Inc. Price Target Cut to C$3.25/Share From C$3.75 by Canaccord Genuity
Organigram Holdings Inc. Price Target Cut to C$3.25/Share From C$3.75 by Canaccord Genuity
Earnings Call Summary | OrganiGram(OGI.US) Q2 2024 Earnings Conference
The following is a summary of the Organigram Holdings Inc. (OGI) Q2 2024 Earnings Call Transcript:Financial Performance:Organigram reported increased cash position due to $124.6 million investment fro
Organigram Fiscal Q2 Loss Surges as Revenue Falls 5%
Organigram Holdings (NASDAQ and TSX: OGI), a licensed producer of cannabis, on Tuesday reported a fiscal second-quarter net loss of $27.1 million, more than triple the loss of $7.5 million a year earl
OrganiGram: Fiscal Q2 Earnings Snapshot
OrganiGram | 6-K: Report of foreign private issuer (related to financial reporting)
Organigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International Markets
Canadian cannabis company Organigram Holdings Inc.(NASDAQ:OGI) (TSX:OGI) reported its financial results Tuesday for the second quarter that ended March 31, 2024, revealing net revenue of CA$37.63 mill
OrganiGram 2Q Loss Widens
By Adriano Marchese OrganiGram Holdings on Tuesday reported a wider loss in its second fiscal quarter on the back of fair-value changes on its balance sheet in the quarter. For the three months ende
Organigram's Strong Q2 Growth and Strategic Moves
Organigram Brief: Q2 Fiscal 2024 Net Loss Was $27.1 Million Compared to $7.5 Million in Q2 Fiscal 2023
06:14 AM EDT, 05/14/2024 (MT Newswires) -- Organigram Brief: Q2 Fiscal 2024 Net loss was $27.1 million compared to $7.5 million in Q2 Fiscal 2023
Organigram Q2 Fiscal 2024 Net Loss Was C$27.1M Compared To C$7.5M A Year Ago
Organigram Q2 Fiscal 2024 Net Loss Was C$27.1M Compared To C$7.5M A Year Ago
OrganiGram Holdings Q2 Sales C$37.628M Miss C$38.025M Estimate
OrganiGram Holdings Q2 Sales C$37.628M Miss C$38.025M Estimate
OrganiGram Holdings 2Q Rev $37.6M >OGI
OrganiGram Holdings 2Q Rev $37.6M >OGI
Organigram Brief: Q2 Fiscal 2024 Recreational Net Revenue Increased 21% to $33.1 Million From $27.4 Million in the Second Quarter Ended February 28, 2023
06:01 AM EDT, 05/14/2024 (MT Newswires) -- Organigram Brief: Q2 Fiscal 2024 recreational net revenue increased 21% to $33.1 million from $27.4 million in the second quarter ended February 28, 2023
Press Release: Organigram Reports Second Quarter Fiscal 2024 Results
Organigram Reports Second Quarter Fiscal 2024 Results -- 21% growth in recreational net revenue year-over-year -- First Jupiter private placement tranche closed adding $41.5 million of
Organigram Reports Second Quarter Fiscal 2024 Results
21% growth in recreational net revenue year-over-year First Jupiter private placement tranche closed adding $41.5 million of cash bringing Organigram's closing cash balance at quarter-end to $83.6 m
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis Stock Movers For May 9, 2024
GAINERS:Global Hemp Group (OTC:GBHPF) shares closed up 100.00% at $0.06MJ Holdings (OTC:MJNE) shares closed up 24.56% at $0.01SOL Glb Inv (OTC:SOLCF) shares closed up 18.47% at $0.03MariMed (OTC:MRMD)
Organigram to Unveil Q2 Fiscal 2024 Financials
Organigram to Announce Q2 Fiscal 2024 Earnings
Press Release: Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024
Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024 TORONTO--(BUSINESS WIRE)--May 08, 2024-- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram I
No Data